Teva buys Mexican pharmaceutical company Rimsa for $2.3 billion
Teva CEO says acquisition delivers on strategy of increasing presence in key emerging markets.
Teva Pharmaceutical Industries building in Jerusalem.(photo credit: MARC ISRAEL SELLEM/THE JERUSALEM POST)